Growth Metrics

Madrigal Pharmaceuticals (MDGL) Operating Income Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 32.96%
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -50.81%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 13.47%
7 Evaxion A 64.16 Bn 64.14 Bn - 16.35%
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 55.96%
10 Madrigal Pharmaceuticals 14.44 Bn 14.20 Bn - -5.78%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.78%
Dec 31, 2025 11.26%
Sep 30, 2025 -12.33%
Jun 30, 2025 12.42%
Mar 31, 2025 -11.26%
Dec 31, 2024 -1.22%
Sep 30, 2024 -22.57%
Jun 30, 2024 -38.08%
Mar 31, 2024 -42.11%
Dec 31, 2023 -25.31%
Sep 30, 2023 -18.79%
Jun 30, 2023 -19.76%
Mar 31, 2023 -27.26%
Dec 31, 2022 -41.74%
Sep 30, 2022 -49.23%
Jun 30, 2022 -45.73%
Mar 31, 2022 -47.03%
Dec 31, 2021 -64.72%
Sep 30, 2021 -77.30%
Jun 30, 2021 -99.07%
Mar 31, 2021 -95.70%
Dec 31, 2020 -88.36%
Sep 30, 2020 -89.51%
Jun 30, 2020 -81.34%
Mar 31, 2020 -84.26%
Dec 31, 2019 -56.90%
Sep 30, 2019 -19.75%
Jun 30, 2019 -104.91%
Mar 31, 2019 -190.64%
Dec 31, 2018 -11.67%
Sep 30, 2018 -134.40%
Jun 30, 2018 26.24%
Mar 31, 2018 29.68%
Dec 31, 2017 23.49%
Sep 30, 2017 23.71%
Jun 30, 2017 27.01%
Mar 31, 2017 35.75%
Dec 31, 2016 30.84%
Sep 30, 2016 13.53%
Jun 30, 2016 50.73%
Mar 31, 2016 66.85%
Dec 31, 2015 16.30%
Sep 30, 2015 60.74%
Jun 30, 2015 -11.33%
Mar 31, 2015 -11.76%
Dec 31, 2014 -24.78%
Sep 30, 2014 -16.76%
Jun 30, 2014 -21.80%
Mar 31, 2014 -27.83%
Dec 31, 2013 -40.99%
Sep 30, 2013 -28.67%
Jun 30, 2013 -34.62%